AstraZeneca to acquire Icosavax in $1.1bn deal to boost vaccine development

Pallavi Madhiraju- December 13, 2023 0

In a definitive move, AstraZeneca has entered into an agreement to acquire Icosavax, Inc., a U.S.-based biopharmaceutical company specializing in innovative vaccines. This acquisition, valued ... Read More

Takeda Pharmaceutical acquires celiac disease drug developer PvP Biologics

pharmanewsdaily- February 28, 2020 0

Takeda acquisition of PvP Biologics : Japanese pharma giant Takeda Pharmaceutical Company has acquired US-based celiac disease drug developer PvP Biologics in a deal worth ... Read More